![](/img/cover-not-exists.png)
F13Beyond clinical trials: a real life multicenter Italian experience on Fulvestrant 500mg in postmenopausal women with hormone-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer (MBC)
Palumbo, R., Ferzi, A., Gambaro, A., Tagliaferri, B., Sottotetti, F., Licata, L., Teragni, C., Pozzi, E., Bernardo, A.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw337.13
Date:
September, 2016
File:
PDF, 63 KB
2016